SCHEMBL2065293

SCHEMBL2065293

Cc1ccc(-c2ccc3nc(-c4ccc(Cl)cc4)cn3c2)cc1CO

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 8/20 0.65
KCNH2 Q12809 2/20 0.65
CYP2C9 P11712 1/20 0.65
ALDH1A3 P47895 6/20 0.56
ALDH1A1 P00352 4/20 0.56
NPC1 O15118 4/20 0.56
RAB9A P51151 4/20 0.56
APP P05067 1/20 0.48
SLC2A1 P11166 1/20 0.48
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
MITF O75030 1/20 0.47
KDM5A P29375 1/20 0.47
KDM5C P41229 1/20 0.47
KMT2A Q03164 1/20 0.47
PAX8 Q06710 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
ALDH1A2 O94788 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2063105 0.86 NR4A2 (0.67) NR4A2KCNH2CYP2C9ALDH1A3ALDH1A1
SCHEMBL2064887 0.81 NR4A2 (0.66) NR4A2KCNH2CYP2C9ALDH1A3ALDH1A1
SCHEMBL2064908 0.81 NR4A2 (0.72) NR4A2KCNH2CYP2C9ALDH1A3ALDH1A1
SCHEMBL2064757 0.80 NR4A2 (0.79) NR4A2KCNH2CYP2C9ALDH1A3ALDH1A1
SCHEMBL1474903 0.79 NR4A2 (0.70) NR4A2KCNH2CYP2C9ALDH1A3ALDH1A1
SCHEMBL1472851 0.79 NR4A2 (1.00) NR4A2KCNH2CYP2C9ALDH1A3ALDH1A1
SCHEMBL2063933 0.79 NR4A2 (0.76) NR4A2KCNH2CYP2C9ALDH1A3ALDH1A1
Hydrochloric Acid SCHEMBL1472603 0.78 NR4A2 (0.98) NR4A2KCNH2CYP2C9ALDH1A3ALDH1A1
SCHEMBL1472244 0.78 NR4A2 (0.78) NR4A2KCNH2CYP2C9ALDH1A3ALDH1A1
SCHEMBL7673877 0.77 ALOX5 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2262803-B1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[L,2-A] PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2012-10-17 EP claimed
US-8148370-B2 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[1,2-a]pyridines, and preparation and therapeutic use thereof SANOFI-AVENTIS (FR) 2012-04-03 US claimed
US-20110065699-A1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-03-17 US claimed
EP-2262803-B1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[L,2-A] PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2012-10-17 EP disclosed
US-8148370-B2 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[1,2-a]pyridines, and preparation and therapeutic use thereof SANOFI-AVENTIS (FR) 2012-04-03 US disclosed
US-20110065699-A1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065699-A1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF ABL1, JAK2, REN NR4A2 1531/4885KCNH2 1429/4885CYP2C9 408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.